Aclaris Therapeutics, Inc.

Q1 2023 13F Holders

Symbol
ACRS
CUSIP
00461U105
Type
Equity
Class
COM
Num filers
153
Total reported value, excl. options
$579M
Manager Report Date Value ($000) Shares Option Type